Introduction {#section5-1179546820927402}
============

Coronary artery disease (CAD) is the leading cause of morbidity and mortality in the developed world. The rapid rise in CAD burden over recent decades can be attributed to socioeconomic changes, increase in life expectancy, and acquisition of lifestyle-related risk factors.^[@bibr1-1179546820927402]^ Patients with established CAD are at increased risk of premature death, myocardial infarction, and rehospitalization, and as such, international guidelines advocate for adherence to secondary prevention strategies following diagnosis.^[@bibr2-1179546820927402]^

Cardiac rehabilitation programs provide a comprehensive framework for the institution of secondary preventive measures, such as evidence-based pharmacotherapy, cardiac risk factor optimization, and diet and physical activity recommendations.^[@bibr3-1179546820927402]^ There is extensive literature to date supporting these interventions, with a recent Cochrane review revealing a 13% decrease in all-cause mortality and a 26% decrease in cardiovascular mortality in participants of structured rehabilitation programs.^[@bibr4-1179546820927402]^ Despite this, cardiac rehabilitation programs remain generally underutilized, with poor referral and completion rates.^[@bibr5-1179546820927402][@bibr6-1179546820927402][@bibr7-1179546820927402][@bibr8-1179546820927402]-[@bibr9-1179546820927402]^ When referred, the commencement of cardiac rehabilitation can be delayed weeks to months post the index event, and can cause a delay in the resumption of work.^[@bibr10-1179546820927402]^ Furthermore, the opportunity to immediately reinforce the importance of physical activity and lifestyle change is lost. As such, novel models of care have been considered in this population.

Digital health interventions for secondary prevention offer an effective alternative to traditional cardiac rehabilitation and can be implemented immediately.^[@bibr11-1179546820927402],[@bibr12-1179546820927402]^ Early research in this field predominantly focused on telehealth interventions, defined as provision of healthcare via telephone calls, Internet, and videoconferencing,^[@bibr13-1179546820927402]^ which although effective, still pose a strain on resource utilization. Smartphone technology is an advance on previous telehealth interventions and can provide an automated platform for a patient-centered program with the capacity to incorporate education, motivation, reminders, and support.^[@bibr3-1179546820927402]^

Although promising, most of the available evidence in this field is based on pilot and feasibility studies with widely varying treatment lengths and digital intervention types.^[@bibr14-1179546820927402][@bibr15-1179546820927402][@bibr16-1179546820927402][@bibr17-1179546820927402][@bibr18-1179546820927402][@bibr19-1179546820927402][@bibr20-1179546820927402]-[@bibr21-1179546820927402]^ The exponential growth and availability of smartphone technology may provide a novel tool to optimize secondary prevention of coronary heart disease. This form of digital intervention can be accessed anywhere, at any time, overcoming geographic and resource associated limitations of healthcare delivery and as such has the potential to revolutionize the landscape of secondary prevention. However, the overall value of this approach remains unclear. Accordingly, we have performed a systematic review and meta-analysis comparing the effectiveness of smartphone-based secondary prevention to traditional cardiac rehabilitation programs in the optimization of secondary prevention in patients with CAD.

Methods {#section6-1179546820927402}
=======

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) Statement^[@bibr22-1179546820927402]^ was followed ([Figure 1](#fig1-1179546820927402){ref-type="fig"}) ([Table S3](https://journals.sagepub.com/doi/suppl/10.1177/1179546820927402)). A comprehensive literature search was performed through MEDLINE, EMBASE, PubMed, and the Cochrane Library from establishment to April 2019 using the following search areas: "smartphone," "rehabilitation," and "coronary artery disease" ([Table S1](https://journals.sagepub.com/doi/suppl/10.1177/1179546820927402)). Articles were screened based on title and abstract. Full text of the articles meeting the inclusion criteria based on initial screening were then reviewed. Two reviewers (A.C.M. and G.M.) independently extracted the data and resolved conflicts by consensus. Reference lists of reviewed articles were screened to identify further relevant studies.

![Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flow diagram.](10.1177_1179546820927402-fig1){#fig1-1179546820927402}

Studies included were not limited by date, location of study, study design, or publication status. Inclusion criteria were as follows: (1) studies performed in adult patients with established CAD; (2) study design involving a comparison of patients undergoing smartphone-based cardiac rehabilitation against patients undergoing traditional outpatient-based cardiac rehabilitation; (3) studies published in English. In the case of multiple publications involving the same patient cohort, we used the longest available follow-up. A quality assessment of both randomized and nonrandomized controlled trials was performed using the van Tulder scale ([Table S2](https://journals.sagepub.com/doi/suppl/10.1177/1179546820927402)).^[@bibr23-1179546820927402]^ The van Tulder scale evaluates 11 components, including randomization, allocation concealment, baseline characteristics, patient blinding, caregiver blinding, observer blinding, cointervention, compliance, dropout rate, end point assessment time point, and intention to treat analysis. Studies scoring 5 or more points on the 11-point scale were deemed to be of high quality. Two reviewers (A.C.M., G.M.) independently extracted the data and resolved conflicts by consensus.

The outcomes of interest were exercise capacity as measured by the 6-minute walk test (6-MWT, meters), systolic blood pressure (SBP, mmHg), low-density lipoprotein cholesterol (LDL-C, mmol/L), and body mass index (BMI, kg/m^2^). Diastolic blood pressure (DBP), high-density lipoprotein cholesterol (HDL-C), total cholesterol, medication adherence, clinical events (acute myocardial infarction \[AMI\], unplanned revascularization, stroke, mortality, and recurrent cardiac hospitalization), weight, waist circumference (WC), resting heart rate (RHR), smoking status, glucose levels, and glycated hemoglobin (HbA1c) levels were evaluated on secondary analyses.

Statistical analysis {#section7-1179546820927402}
--------------------

Descriptive statistics are presented as mean and standard deviation for continuous variables and absolute and relative frequencies for categorical variables. Continuous outcomes were analyzed using an inverse variance method based on a Der Simonian and Laird random-effects model to estimate the mean differences with 95% confidence intervals (CIs). Random-effect analysis was prespecified in preference to a fixed-effects model in this study due to clinical variations in study types and populations assessed. Statistical heterogeneity was quantified using the *I*^2^ statistic. The *I*^2^statistic provides an estimate of the amount of variance due to heterogeneity rather than chance and is based on the traditional measure of variance, the Cochrane Q statistic. *I*^2^ ⩾ 75% was considered to indicate significant interstudy heterogeneity.^[@bibr24-1179546820927402]^ As the number of included studies was less than 10, we did not perform tests to ascertain publication bias.^[@bibr25-1179546820927402]^ We considered a *P* value \< .05 as statistically significant. Statistical analyses were performed and Forest plots generated using comprehensive meta-analysis using the reported study data (Version 3, Biostat, Englewood, NJ).

Results {#section8-1179546820927402}
=======

A total of 8 studies (7 randomized controlled trials and 1 observational case-control study) examining 1120 patients were included in the quantitative analysis.^[@bibr14-1179546820927402][@bibr15-1179546820927402][@bibr16-1179546820927402][@bibr17-1179546820927402][@bibr18-1179546820927402][@bibr19-1179546820927402]-[@bibr20-1179546820927402],[@bibr26-1179546820927402]^ Overall study quality was deemed high in all eight studies. Follow-up ranged from 6 weeks to 12 months and the indication for cardiac rehabilitation varied. Five studies examined all patients post acute coronary syndrome (ACS),^[@bibr14-1179546820927402][@bibr15-1179546820927402][@bibr16-1179546820927402][@bibr17-1179546820927402]-[@bibr18-1179546820927402]^ 2 studies examined only patients undergoing percutaneous coronary intervention (PCI),^[@bibr20-1179546820927402],[@bibr26-1179546820927402]^ and 1 study examined all patients with a diagnosis of CAD, independent of intervention.^[@bibr19-1179546820927402]^ Compliance with follow-up assessments varied from 83% to 100% in the smartphone group compared with 44% to 100% in the control group. Study and patient characteristics are presented in [Table 1](#table1-1179546820927402){ref-type="table"}. A summary of the smartphone interventions has been included in [Table 2](#table2-1179546820927402){ref-type="table"}. Due to significant heterogeneity in outcome reporting, clinical events such as acute myocardial infarction, unplanned revascularization, stroke, mortality, and recurrent cardiac hospitalization were not analyzed.

###### 

Study and patient characteristics.

![](10.1177_1179546820927402-table1)

                                           Blasco 2012   Varnfield 2014   Widmer 2015    Johnston 2016   Widmer 2017   Maddison 2019   Fang 2019     Dorje 2019
  ---------------------------------------- ------------- ---------------- -------------- --------------- ------------- --------------- ------------- ------------
  Smartphone intervention (n)              102           53               25             86              34            82              33            156
  Traditional cardiac rehabilitation (n)   101           41               19             80              37            80              34            156
  Design                                   RCT           RCT              Case-Control   RCT             RCT           RCT             RCT           RCT
  Program duration                         12 months     6 months         3 months       6 months        3 months      3 months        6 weeks       6 months
  Population                               ACS           ACS              ACS            ACS             ACS           CAD             Post PCI      Post PCI
  Follow-up time point                     12 months     6 months         6 months       6 months        6 months      6 months        6 weeks       12 months
  Follow-up completion (%)                                                                                                                           
   Smartphone CR                           88            77               89             93              92            94              83            100
   Traditional CR                          91            43               44             93              85            98              85            100
  Age (years)                                                                                                                                        
   Smartphone CR                           60.6 ± 11.5   54.9 ± 9.6       60.2 ± 12.1    56.8 ± 8.0      61.0 ± 13.2   62.5 ± 10.7     60.2 ± 9.4    59.1 ± 9.4
   Traditional CR                          61 ± 12.1     56.2 ± 10.1      70.4 ± 9.9     58.4 ± 8.6      61.5 ± 12.2   63.6 ± 10.9     61.4 ± 10.2   61.9 ± 8.7
  Male (%)                                                                                                                                           
   Smartphone CR                           81            91               76             83              84            78              64            82
   Traditional CR                          80            83               89             79              88            85              62            81
  BMI (kg/m^2^)                                                                                                                                      
   Smartphone CR                           28.2 ± 5.3    NR               29.2 ± 4.4     28.9 ± 5.6      29.1 ± 4.6    31.4 ± 5        NR            25.3 ± 3.0
   Traditional CR                          27.7 ± 3.5    NR               30.6 ± 5.6     28.4 ± 4.7      27.9 ± 3.5    30.5 ± 6.0      NR            25.4 ± 3.5
  Hypertension (%)                                                                                                                                   
   Smartphone CR                           NR            42               95             46.5            65            82              46            NR
   Traditional CR                          NR            51               93             47.5            61            70              41            NR
  Diabetes (%)                                                                                                                                       
   Smartphone CR                           NR            15               27             9.3             18            32              27            NR
   Traditional CR                          NR            20               33             16.3            18            13              38            NR
  Hyperlipidemia (%)                                                                                                                                 
   Smartphone CR                           NR            55               68             27.9            77            97              NR            NR
   Traditional CR                          NR            46               71             16.3            88            93              NR            NR
  Smoker (%)                                                                                                                                         
   Smartphone CR                           77            5                14             NR              0             3               NR            56
   Traditional CR                          74            10               11             NR              1             15              NR            57

Abbreviations: ACS, acute coronary syndrome; BMI, body mass index; CAD, coronary artery disease; CR, cardiac rehabilitation; NR, not recorded; PCI, percutaneous coronary intervention; RCT, randomized controlled trial.

###### 

Smartphone interventions.

![](10.1177_1179546820927402-table2)

  Author      Date   Smartphone intervention
  ----------- ------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Blasco      2012   Patient-measured blood pressure, lipid profile, and glucose levels are entered into an app-based questionnaire. The medical team analyze the data and send management advice via the app.
  Varnfield   2014   The inbuilt health system in the smartphone monitors daily activity. The platform allows for delivery of motivational and educational materials to participants. The program is connected to a web portal and weekly data are entered for monitoring by the medical team.
  Widmer      2015   The inbuilt health system in the smartphone monitors daily activity and further information is inputted by the patient. The platform allows for delivery of motivational and educational materials to participants. Automated messages are sent to encourage compliance with the program.
  Johnston    2016   Patients are given an exercise program and drug adherence diary to complete and data regarding these behaviors are inputted into the app. The platform allows for delivery of motivational and educational materials to participants. Automated messages are sent to encourage compliance with the program.
  Widmer      2017   Patients are given an exercise program to complete and data regarding dietary and exercise behaviors are inputted into the app. The platform allows for delivery of motivational and educational materials to participants. Automated messages are sent to encourage compliance with the program.
  Maddison    2019   The inbuilt health system in the smartphone monitors daily activity. Patients are given an individualized exercise program to complete and data regarding dietary and exercise behaviors are inputted into the app. The platform allows for delivery of motivational and educational materials to participants. Automated messages are sent to encourage compliance with the program.
  Fang        2019   Patients were fitted with remote monitoring system which communicated with the inbuilt health system in the smartphone to monitor daily activity. The platform allows for delivery of motivational and educational materials to participants.
  Dorje       2019   The inbuilt health system in the smartphone monitors daily activity. The platform allows for delivery of motivational and educational materials to participants. The program is connected to a web portal and weekly data are entered for monitoring by the medical team.

The results of the meta-analysis of the outcomes of interest are presented in [Figure 2](#fig2-1179546820927402){ref-type="fig"}. Exercise capacity, as measured by the 6MWT, was significantly greater in the smartphone group (20.10 meters, 95% CI 7.44-33.97; *P* \< 0.001; *I*^2^ = 45.58). There was a numerical reduction in BMI in the smartphone group seen across studies, but this was not statistically significant (--0.53 kg/m^2^, 95% CI --1.10 to 0.05; *P* = .07, *I*^2^ = 32.0%). There was no significant difference in systolic blood pressure or LDL cholesterol levels between groups(--0.63 mmHg, 95% CI --3.41 to 2.15; *P* = .66, *I*^2^ = 0% and 0.01 mmol/L, 95% CI --3.41 to 2.15; *P* = .97, *I*^2^ = 90% respectively). Similarly DBP, HDL-C, total cholesterol, medication adherence, clinical events, weight, WC, RHR, smoking status, or glycemic control were comparable between groups (*P* value for all \> .05) as assessed on secondary analyses.

![Meta-analysis of the primary endpoints.](10.1177_1179546820927402-fig2){#fig2-1179546820927402}

Discussion {#section9-1179546820927402}
==========

The purpose of this study was to compare the effectiveness of smartphone-based interventions to traditional cardiac rehabilitation for secondary prevention in patients with CAD. On review of the literature, smartphone technology appears well received by patients. The results of the meta-analysis demonstrate that the application of smartphone-based interventions in studies ranging from 6 weeks to 12 months has a beneficial effect on 6MWT capacity. Both smartphone-based and traditional cardiac rehabilitation had comparable outcomes in the other measured secondary prevention parameters.

The number of smartphone users today surpasses 3 billion and is predicted to grow by several hundred million.^[@bibr27-1179546820927402]^ Smartphone users can now access interactive applications from anywhere at any time. As such, there is great potential for the delivery of digital health interventions via smartphone technology. Traditional cardiac rehabilitation programs require dedicated multidisciplinary involvement and expend significant hospital resources. Furthermore, compliance is reliant on patient availability to attend multiple visits per week which may be impacted by employment and household commitments.^[@bibr10-1179546820927402]^ Unfortunately, specific compliance with the smartphone application was not reported in the included studies, despite discussion comments made of general acceptability and usability of the technology. Follow-up rates were largely similar between groups, except for 2 studies where follow-up in the smartphone group was roughly double that of the traditional cardiac rehabilitation group.^[@bibr15-1179546820927402],[@bibr17-1179546820927402]^ Although follow-up assessment cannot be used as a surrogate for compliance, there may be a potential improvement in patient engagement with a smartphone-based platform.

Physical inactivity is independently associated with 12.2% of the global burden of acute myocardial infarction.^[@bibr28-1179546820927402]^ Accordingly, physical activity is a cornerstone of secondary prevention, with a dose-response relationship existing between 6-MWT and the risk of future cardiovascular events.^[@bibr29-1179546820927402]^ In this analysis, smartphone-based cardiac rehabilitation was associated with a greater improvement in exercise capacity when compared with traditional programs. Dorje et al^[@bibr26-1179546820927402]^ have attributed this benefit to the high level of participant engagement, achieved as a result of the system's remote activity monitoring, timely feedback, and positive reinforcement measurements. In contrast, compliance with exercise recommendations is still far from desirable in traditional cardiac rehabilitation programs and may contribute to poorer long-term outcomes.^[@bibr30-1179546820927402]^

Blood pressure and cholesterol control are important secondary prevention targets. A meta-analysis by Ettehad et al^[@bibr31-1179546820927402]^ of over 600 000 adults indicated that a 10 mmHg reduction in systolic blood pressure is associated with a 20% reduction in major cardiovascular events and 13% reduction in all-cause mortality. In addition, with every 1 mmol/L decline in LDL cholesterol concentration, there is a 21% reduction in cardiovascular events.^[@bibr32-1179546820927402]^ As such, close monitoring and aggressive treatment of these parameters are paramount to the optimal management of patients with CAD. Although the pooled analysis in this study did not show a significant advantage of smartphone technology over traditional cardiac rehabilitation in the management of cardiac risk factors, the authors acknowledge the positive results of the large-scale SMART-CR/SP trial by Dorje et al^[@bibr26-1179546820927402]^ published in 2019. This was the first randomized controlled trial to show the efficacy of smartphone-based home cardiac rehabilitation in all outcome domains. Although further research is required to support the clinical significance of these findings, this study highlights the potential of smartphone technology as an effective and accessible alternative to traditional rehabilitation programs.

The majority of available evidence in the field of digital health intervention for secondary prevention is based on pilot and feasibility studies with widely varying treatment lengths and intervention types. To our knowledge, this is the first meta-analysis examining only smartphone-based interventions, which is a strength of this study. Furthermore, the assessment of study quality was high which increases the generalizability of our findings. A significant limitation is the intermediate duration of follow-up. In addition, outcome assessments in some studies may be subject to bias due to them being unblinded to the treatment type. As we did not have access to individual study data, we were unable to stratify study outcomes at a specific time period. The variability in patient follow-up may have affected the results of our analysis. As such, the results of this meta-analysis are merely hypothesis generating rather than conclusive. Further studies are required to examine the impact of smartphone-based intervention on clinical events such as acute myocardial infarction, unplanned revascularization, stroke, mortality, and recurrent cardiac hospitalization as these are important measures of success of a secondary prevention program.

Conclusion {#section10-1179546820927402}
==========

Publicly available smartphone-based cardiac rehabilitation programs are a convenient and easily disseminated intervention which show merit in exercise promotion in patients with established CAD. Further research is required to establish the clinical significance of recent findings favoring their use. In particular, larger studies which are adequately powered for clinical endpoints and with longer follow-up are needed to ascertain the effectiveness and sustainability in the long term. In the interim, implementation of these strategies should be considered for the many cardiac patients without access to cardiac rehabilitation and secondary prevention services.

Supplemental Material {#section11-1179546820927402}
=====================

###### mHealth_Supplement -- Supplemental material for Efficacy of Smartphone-Based Secondary Preventive Strategies in Coronary Artery Disease

###### 

Click here for additional data file.

Supplemental material, mHealth_Supplement for Efficacy of Smartphone-Based Secondary Preventive Strategies in Coronary Artery Disease by Alexandra C Murphy, Georgina Meehan, Anoop N Koshy, Phelia Kunniardy, Omar Farouque and Matias B Yudi in Clinical Medicine Insights: Cardiology

**Funding:**The author(s) received no financial support for the research, authorship, and/or publication of this article.

**Declaration of Conflicting Interests:**The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

**Author Contributions:** All authors had access to the data and a role in writing the manuscript.

**ORCID iDs:** Alexandra C Murphy ![](10.1177_1179546820927402-img1.jpg) <https://orcid.org/0000-0002-4248-7537>

Georgina Meehan ![](10.1177_1179546820927402-img1.jpg) <https://orcid.org/0000-0002-1365-7461>

**Supplemental Material:** Supplemental material for this article is available online.

[^1]: Alexandra C Murphy and Georgina Meehan are co-first authors.
